Precision Medicine

NImmune Biopharma has recently announced a strategic partnership with BioTherapeutics aimed at accelerating the development of precision medicines for inflammation and immunology. The collaboration is designed to bolster NImmune’s capabilities by integrating BioTherapeutics’ extensive preclinical se

The biopharmaceutical industry is in a state of flux, marked by the FDA's scrutiny of immunotherapy drugs, financial challenges faced by biotech startups, and promising advancements in vaccine development and obesity treatments. As regulatory, operational, and market dynamics evolve, companies

The biopharmaceutical industry, or biopharma, stands at the forefront of medicine and biotechnology, bringing revolutionary advancements to patient care and medical treatments. Biopharma focuses on developing drugs from biological sources, offering a wide range of therapies that are changing lives.

The biopharmaceutical industry stands at the forefront of medical innovation, driving advances that significantly impact healthcare and treatment options worldwide. This sector involves developing and producing drugs derived from biological sources and is continually evolving with breakthroughs

The pharmaceutical industry is undergoing a significant transformation driven by the advent of pharma analytics. Utilizing modern data analytics tools has revolutionized various stages of drug development, manufacturing, and distribution. This article explores how these advancements are shaping the

In a recent strategic maneuver, Myriad Genetics, Inc., known for its pioneering work in genetic testing and precision medicine, officially announced the sale of its EndoPredict business unit to Eurobio Scientific. Based in Salt Lake City, Utah, Myriad's decision aligns with broader plans to